Drawing for G GMETIC GLOBAL MEDICINES AND TECHNOLOGY INNOVATION CENTER

USPTO serial 79236581

G GMETIC GLOBAL MEDICINES AND TECHNOLOGY INNOVATION CENTER

Reviewed by CopyMark Law Group

Reg. 5766374Status 709
Filing date
Status date
Registration date
Jun 4, 2019
Examiner
SALES, HEATHER ALISON
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with G GMETIC GLOBAL MEDICINES AND TECHNOLOGY INNOVATION CENTER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael T. Murphy

MICHAEL T. MURPHY GLOBAL IP COUNSELORS, LLP1233 TWENTIETH STREET NWSUITE 600WASHINGTON, DC 20036

Goods and services

ClassDescriptionStatusFirst use
016Printed matter, namely, newspapers, photographs, magazines, books, printed periodicals, newsletters, printed research reports, journals and brochures all in the fields of medicineSECTION 71 - CANCELLED—
035Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approvalSECTION 71 - CANCELLED—
036Financing medical research of othersSECTION 71 - CANCELLED—
041Arranging and conducting educational conferences; arranging and conducting educational congresses in the field of medicine; arranging and conducting business seminars in the field of medicineSECTION 71 - CANCELLED—
042Medical research; medical and scientific research, namely, conducting clinical trials for others; medical and scientific research in the field of infectious diseases; medical and scientific research in the field of bacteriology; medical and scientific research in the field of immunologySECTION 71 - CANCELLED—
044Provision of medical information; providing health information; health care; physical examination services; collection and preservation of human blood; medical and pharmaceutical consultation; medical servicesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 19, 2026INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Dec 19, 2025C71TCANCELLED SECTION 71—
Jun 4, 2024REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Nov 15, 2019FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 17, 2019XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Sep 17, 2019XXCRGENERIC MADRID TRANSACTION CREATED—
Sep 4, 2019FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 4, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 19, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 19, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 16, 2019GPNXNOTIFICATION PROCESSED BY IB—
Feb 27, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 27, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 27, 2019OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 14, 2019PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 13, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 11, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Feb 11, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 11, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 11, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 28, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 28, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 25, 2019ALIEASSIGNED TO LIE—
Jan 21, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 25, 2018RFNTREFUSAL PROCESSED BY IB—
Aug 9, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 9, 2018RFRRREFUSAL PROCESSED BY MPU—
Jul 31, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 28, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 27, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 26, 2018DOCKASSIGNED TO EXAMINER—
Jul 26, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 25, 2018LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Jul 19, 2018REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance